MedTrace Logo

Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache

NCT02933060 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-07-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether patients in the emergency department with migraine headache who are administered an intravenous fluid bolus will report greater improvement in pain scores than control patients.

Conditions

  • Migraine Headache

Interventions

OTHER

Normal saline (1000 mL)

OTHER

Control

Sponsors & Collaborators

  • The Cooper Health System

    lead OTHER

Principal Investigators

  • Christopher Jones, MD · Cooper Medical School of Rowan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-09-26
Completion
2017-09-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02933060 on ClinicalTrials.gov